Neurology

Registered on ClinicalTrials

Results of an international multicenter, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of sequential therapy with ethylmethylhydroxypyridine succinate in patients in the acute and early recovery periods of ischemic stroke (IS)

The results of a cohort -center randomized study of the modulating effect of Mexidol® in the rehabilitation of patients who have undergone acute cerebral failure

The value of mitochondrial dysfunction in stabilization

The results of a multicenter dual blind randomized placebo-controlled clinical study on the assessment of the effectiveness and safety of the drug Mexidol in the treatment of attention deficit syndrome in children (mega)

The results of an international multicenter randomized double-blind-controlled study of evaluating the effectiveness of the effectiveness and safety of consistent therapy of patients with chronic brain ischemia with Mexidol and Mexidol Forte 250 (study of Memo)

The results of a randomized double blind multicenter placebo-controlled in parallel groups of the study and safety of Mexidol with prolonged consistent therapy in patients in the acute and early recovery periods

The results of a cohort -center randomized study of the modulating effect of Mexidol® in the rehabilitation of patients who have undergone acute cerebral failure

The value of mitochondrial dysfunction in stabilization

Влияние нейропротекторов на уровень BDNF, фактора некроза опухолей альфа и маркеров апоптоза при остром нарушении мозгового кровообращения

Алексей Владимирович Щулькин, Иван Владимирович Черных, Юлия Владимировна Абаленихина, Мария Валерьевна Гацанога, Дарья Леонидовна Кочеткова, Николай Анатольевич Кружалов, Евгения Владимировна Крестинина, Елена Николаевна Якушева

FGBOU in the Ryazan State Medical University named after Academician I.P. Pavlova "of the Ministry of Health of Russia, Ryazan, Russia

Place of publication:

Журнал неврологии и психиатрии им. С.С. Корсакова 2026, т. 126, №2, с. 123–129

Межлекарственные взаимодействия при применении препарата Мексидол у пациентов с ишемическим инсультом: анализ данных рандомизированных клинических исследований

Евгения Валерьевна Ших, Николай Анатольевич Шамалов, Станислав Николаевич Янишевский, Иван Александрович Щукин

ФГАОУ ВО «Первый Московский государственный медицинский университет им. И.М. Сеченова Минздрава России» (Сеченовский Университет), Москва, Россия;

FSBI "Federal Center for Brain and Neurotechnology" of the Federal Medical and Biological Agency of Russia, Moscow, Russia;

ФГБУ «Национальный медицинский исследовательский центр имени В.А. Алмазова» Минздрава России, Санкт-Петербург, Россия;

FGAOU in Russian National Research Medical University named after N.I. Pirogov »Ministry of Health of Russia, Moscow, Russia

Place of publication:

Журнал неврологии и психиатрии им. С.С. Корсакова 2026, т. 126, №3, с. 141–154

Оценка нейропротекторной активности Мексидола на модели геморрагического инсульта

Алексей Владимирович Щулькин, Иван Владимирович Черных, Сергей Константинович Правкин, Юлия Владимировна Абаленихина

FGBOU in the Ryazan State Medical University named after Academician I.P. Pavlova "of the Ministry of Health of Russia, Ryazan, Russia

Place of publication:

Журнал неврологии и психиатрии им. С.С. Корсакова 2026, т. 126, №3, ч. 2, с. 40–45

Современные возможности лечения сосудистых нейрокогнитивных нарушений с позиций доказательной медицины

Владимир Владимирович Захаров, Павел Андреевич Черноусов

ФГАОУ ВО «Первый Московский медицинский университет им. И.М. Сеченова» Минздрава России (Сеченовский Университет), Москва, Россия

Place of publication:

Журнал неврологии и психиатрии им. С.С. Корсакова 2026, т. 126, №4, ч. 2, с. 76–83

Церебропротективные возможности препарата Мексидол у пациентов с артериальной гипертензией

Софья Александровна Дрешина, Станислав Николаевич Янишевский

ФГБУ «Национальный медицинский исследовательский центр им. В.А. Алмазова» Минздрава России, Санкт-Петербург, Россия

Журнал неврологии и психиатрии им. С.С. Корсакова 2026, т. 126, №4, с. 113–118

What you need to know about cognitive impairment

S.R. Shakirzyanova

Place of publication:
NEW THERAPEUTIC JOURNAL "NON NOCERE" SEPTEMBER 2025

The main mechanisms of development of cognitive impairment

A.N. BOGOLEPOVA

Pirogov Russian National Research Medical University of the Ministry of Health of the Russian Federation
(Pirogov University), Moscow, Russia;
Federal Center for Brain and Neurotechnology of the Federal Medical and Biological Agency of Russia, Moscow, Russia

Oxidate Stress in the Pathogenesis of Chronic Headache

Fedin A.I.

Possibilities of neurocytoprotheiation during reperfusion therapy

Authors:
SHCHUKIN I.A. 1*, 2*, KOLTSOV I.A. 1*, 2*, FIDLER M.S. 1*, GLUKHAREVA A.P. 1*

1* Pirogov Russian National Research Medical University of the Ministry of Health of the Russian Federation
(Pirogov University), Moscow, Russia;
2* Federal Center for Brain and Neurotechnology of the Federal Medical and Biological Agency of Russia, Moscow, Russia

The dynamics of domains of emotional-cognitive and motor disorders in the structure of the PIT syndrome in patients who have undergone acute cerebral failure

Authors:
BELKIN V.A., VASILCHENKO I.E., BELKIN A.A.

Modern approaches to the diagnosis and treatment of autonomic dysfunction syndrome in children

Author:
NEMKOVA S.A.

FGAOU in Russian National Research Medical University named after N.I. Pirogov "of the Ministry of Health of Russia (Pirogov University), Moscow, Russia

Vegetative dysfunction in patients with cerebrovascular diseases and metabolic syndrome

Author:
V.N. SHISHKOVA
, Federal State Budgetary Institution National Medical Research Center for Therapeutic and Preventive Medicine, Ministry of Health of the Russian Federation, Moscow, Russia

The results of a cohort -center randomized study of the modulating effect of Mexidol® in the rehabilitation of patients who have undergone acute cerebral failure

Registered on ClinicalTrials

A.A. BELKIN, V.A. BELKIN, I.E. VASILCENKO, E.A. PINCHUK
ANO "Clinical Institute of the Brain", Sverdlovsk region, Berezovsky, Russia

Link to the study here

Place of publication:
S.S. KORSAKOV JOURNAL OF NEUROLOGY AND PSYCHIATRY, 2024, Vol. 124, No. 4

The effectiveness of the use of Mexidol in combination with revascularization of the brain in the treatment of ischemic stroke

Authors:
A.M. ALASHEEV¹, E.V. LANTSOVA²¹State Healthcare Institution of the Sverdlovsk Region “Sverdlovsk Regional Clinical Hospital No. 1”, Yekaterinburg, Russia;
²OOO “Sciencefiles”, Yekaterinburg, Russia

Cognitive disorders in patients with arterial hypertension

Authors:
V.V. ZAKHAROV^,P.A. CHERNOUSOV^,, K.A. VEKHOVA¹A.N. BOGOLEPOVA³¹I.M. Sechenov First Moscow State Medical University, Ministry of Health of the Russian Federation (Sechenov University), Moscow, Russia;
²N.I. Pirogov Russian National Research Medical University, Ministry of Health of the Russian Federation, Moscow, Russia;
³Federal Center for Brain and Neurotechnology, Federal Medical and Biological Agency of Russia, Moscow, Russia

Place of publication:
S.S. KORSAKOV JOURNAL OF NEUROLOGY AND PSYCHIATRY, 2024, Vol. 124, No. 4, Issue 2

Neurometabolic therapy of moderate cognitive disorders in patients with chronic brain ischemia

Authors:
E.A. ANTIPENKO¹, A.V. SHULYNDIN², K.M. BELYAKOV³

¹Federal State Budgetary Educational Institution of Higher Education, Privolzhsky Research Medical University of the Ministry of Health of the Russian Federation, Nizhny Novgorod, Russia;
²Vectorpharm LLC, Moscow, Russia;
³Nizhny Novgorod Regional Clinical Hospital named after N.A. Semashko, Nizhny Novgorod, Russia

1 2 3 … 7 »